California restaurant owner defies outdoor dining ban: ‘We’re in survival mode’ Chef Rodney Worth says he is in ‘survival mode’
Continue reading »
Children with cancer at no greater risk of severe COVID-19 infection, research shows
Pediatric cancer patients who test positive for COVID-19 do not appear to be at any increased risk of severe COVID-19
Continue reading »
No mortality increase with paclitaxel-coated balloons and stents in peripheral arterial disease
An interim analysis from the Swedish Drug-Elution Trial in Peripheral Arterial Disease (SWEDEPAD) has now been presented. It shows that,
Continue reading »
Ability to predict C-diff mortality nearly doubled with new guidelines
Clostridioides difficile infection (CDI) is the most common health care-associated infection in the United States, causing an estimated 12,800 deaths
Continue reading »
Gestational age linked to ADHD in children with Down syndrome
A new study by the UC Davis MIND Institute finds a connection between gestational age and attention deficit/hyperactivity disorder (ADHD)
Continue reading »
New targeted therapy blocks metabolism in brain cancer cells with genetic vulnerability
Researchers at The University of Texas MD Anderson Cancer Center have developed a novel targeted therapy, called POMHEX, which blocks
Continue reading »
3 million currently contagious with coronavirus in US: report
Dr. Jonathan Rothberg on the development of new at-home rapid coronavirus test Chairman of Homodeus and inventor of ‘Detect’ Dr.
Continue reading »
Low levels of choline in pregnant Black American women associated with higher levels of stress
Researchers at the University of Colorado Anschutz Medical Campus have found that many pregnant Black Americans have low levels of
Continue reading »
CDC: 26.4 percent of U.S. adults with diabetes meet ABCS goals
(HealthDay)—About one in four U.S. adults (26.4 percent) with diabetes meet the combined goals for preventing or delaying complications of
Continue reading »
FDA Approves Expanded Indication for Merck’s Keytruda (pembrolizumab) in Adult Patients With Relapsed or Refractory Classical Hodgkin Lymphoma (cHL)
KENILWORTH, N.J.–(BUSINESS WIRE) October 15, 2020 — Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced
Continue reading »